MedPath

The effectiveness of various treatments in reducing psychosomatic symptoms in patients with gastrointestinal dysfunction type D

Not Applicable
Conditions
Diseases of oesophagus, stomach and duodenum.
K20-K31
Diseases of oesophagus, stomach and duodenum
Registration Number
IRCT20201107049294N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
48
Inclusion Criteria

Patient cooperation to participate in the research
complete the consent form
First referral
Minimum cycle education
Age 60-18 years
Patients with gastrointestinal dysfunction according to ROME III criteria by a gastroenterologist for patients referred to a psychiatric clinic
Diagnosis of gastrointestinal dysfunction with irritable bowel syndrome (IBS)
dyspepsia (FD) or both
Do not take psychiatric drugs with the main purpose of reducing emotions (anxiety, etc.)

Exclusion Criteria

A history of substance abuse or dependence is currently on record during the four months prior to treatment
Use of any type of psychiatric and psychiatric medication based on the record in the four months before the first treatment session
Use of any kind of psychological and counseling services for any mental disorder I and II

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Alexithymia. Timepoint: Before starting, after finishing, two months after finishing. Method of measurement: Toronto Alexithymia Scale.;Stress-Anxiety. Timepoint: Before starting, after finishing, two months after finishing. Method of measurement: DASS-21 Stress-Anxiety-Depression Inventory.;Psychosomatic Symptoms. Timepoint: Before starting, after finishing, two months after finishing. Method of measurement: Takata and Sakata Psychosomatic Complaints Scale.;Gastrointestinal Dysfunction. Timepoint: Before starting, after finishing, two months after finishing. Method of measurement: ROME-III questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath